JPMorgan Chase Financial Company LLC filed a free writing prospectus (FWP) under Rule 433 disclosing the preliminary terms of its 3-Year Uncapped Accelerated Barrier Notes linked to the Nasdaq-100, Russell 2000, and S&P 500 indexes, with a pricing date of November 30, 2026.
JPMorgan Chase Financial Company LLC filed a free writing prospectus (FWP) on November 4, 2026, disclosing the preliminary terms of 5-year Uncapped Accelerated Barrier Notes linked to the iShares MSCI EAFE ETF and the EURO STOXX 50 Index, with a pricing date of November …
Lake Superior Acquisition Corp. filed an 8-K on November 4, 2026, disclosing that on November 3, 2026, it entered into an Amended and Restated Agreement and Plan of Merger and Business Combination Agreement with Openmarkets Group Pty Ltd and related parties, revising the structure …
JPMorgan Chase Financial Company LLC filed a free writing prospectus (FWP) under Rule 433 disclosing the preliminary terms of its 5-Year Russell 2000/S&P 500 Uncapped Accelerated Barrier Notes, with a scheduled pricing date of November 30, 2026.
JPMorgan Chase Financial Company LLC filed a free writing prospectus (FWP) under Rule 433 disclosing the preliminary terms of its 5-year Uncapped Accelerated Barrier Notes linked to the Nasdaq-100 Index, Russell 2000 Index, and S&P 500 Index, with a pricing date of November 30, …
JPMorgan Chase Financial Company LLC filed a free writing prospectus on November 4, 2026, disclosing the preliminary terms of 5-year Uncapped Accelerated Barrier Notes linked to the iShares MSCI EAFE ETF and the EURO STOXX 50 Index, with a pricing date of November 24, …
BioAdaptives, Inc. filed a Form 8-K on November 4, 2026, disclosing that on October 29, 2026, it entered into a Membership Interest Purchase Agreement to acquire 100% of the membership interests of Xycota Biosciences LLC, a preclinical CNS biotechnology company.
Bio-Techne Corporation filed a Form 8-K with the SEC on November 3, 2026, disclosing the issuance of a press release announcing a cash dividend.
ArcBest Corporation filed a Form 8-K with the SEC on November 4, 2026, reporting the issuance of a press release announcing its unaudited third quarter 2026 financial results, along with supplemental information and earnings conference call presentation slides.
Addentax Group Corp. filed a Form 8-K on November 4, 2026, disclosing that it entered into a Share Exchange Agreement on November 3, 2026, under which its subsidiary Yingxi Industrial Chain Investment Co., Ltd. will acquire 100% of Double Cash Finance Limited in exchange …